Cargando…
Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B
For patients undergoing liver transplantation (LT) for hepatitis B virus (HBV)–related liver disease, the current standard of care for preventing reinfection of the allograft is nucleoside analogue therapy combined with hepatitis B immune globulin (HBIG). Entecavir has demonstrated high efficacy and...
Autores principales: | Perrillo, Robert, Buti, Maria, Durand, Francois, Charlton, Michael, Gadano, Adrian, Cantisani, Guido, Loong, Che-Chuan, Brown, Kimberly, Hu, Wenhua, Lopez-Talavera, Juan Carlos, Llamoso, Cyril |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791551/ https://www.ncbi.nlm.nih.gov/pubmed/23788462 http://dx.doi.org/10.1002/lt.23690 |
Ejemplares similares
-
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B
por: Tang, Hong, et al.
Publicado: (2013) -
Large-scale surveillance study of the safety and effectiveness of entecavir in Korean patients with chronic hepatitis B
por: Kim, Chang Wook, et al.
Publicado: (2018) -
The role of entecavir in the treatment of chronic hepatitis B
por: Dimou, Evangelini, et al.
Publicado: (2007) -
Severe Acute Hepatitis B Treated With Entecavir.
por: De Socio, Giuseppe Vittorio Luigi, et al.
Publicado: (2011) -
Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)